the promise of tau aggregation inhibitors in dementia
Published 10 months ago • 163 plays • Length 2:04Download video MP4
Download video MP3
Similar videos
-
3:31
the phase iii lucidity trial: a tau aggregation inhibitor in patients with alzheimer’s disease
-
1:45
promise of tau-pet imaging for alzheimer's disease
-
7:00
sens4 - tau aggregation inhibitor therapy for neurodegenerative disorders (1/2)
-
9:40
sens4 - tau aggregation inhibitor therapy for neurodegenerative disorders (1/2)
-
1:14
research highlight: toxic tau aggregates determines type of dementia
-
2:03
investigating the relationship of tau and amyloid in alzheimer’s disease
-
6:32
the role of tau in autosomal dominant alzheimer’s disease
-
1:14
what do we understand about the secretion of brain p-tau in ad?
-
5:31
the spreading pathways of tau and amyloid
-
2:03
modifiable dementia risk factors associated with higher csf tau and poorer cognition in middle age
-
2:46
value of p-tau231 in early alzheimer’s disease
-
1:12
beyond aβ and p-tau: novel biomarkers under investigation for alzheimer’s disease
-
1:37
methylation regulates tau aggregation and neuronal health in alzheimer’s disease
-
2:17
beyond amyloid & tau: neuroinflammation, rhes & proteomics
-
0:33
the tangled web of tau
-
2:12
bringing tau into the limelight
-
2:03
alzheimer's study shows promise in protecting brain from tau
-
3:48
tau and alzheimer's
-
2:20
14-3-3/tau: the way to an alzheimer's cure?